GlassScriptPhysician profile
Jose A Moreno
NPI 1255594198
$4,686.66
in general payments reported to CMS, 2019-2025
21 companies · $1,825 in 2025
The $1,825 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,634 · 2020: $143 · 2021: $65.24 · 2022: $209 · 2023: $581 · 2024: $230 · 2025: $1,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,497 · Travel and Lodging: $1,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.18 |
| Travel and Lodging | $1,139.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $1,663.11 | 2025 | Phasix Mesh |
| Covidien LP | $919.05 | 2019-2020 | |
| Davol INC. | $442.39 | 2020-2025 | Phasix Mesh |
| Tela Bio, INC. | $401.81 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Asensus Surgical, INC. | $259.28 | 2019 | |
| Intuitive Surgical, INC. | $252.81 | 2019-2024 | |
| Integra Lifesciences Corporation | $181.23 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $133.49 | 2023-2025 | Collagenase Santyl, Pico, Renasys Touch |
| Medtronic, INC. | $73.44 | 2023-2024 | Progrip |
| Pacira Pharmaceuticals Incorporated | $70.78 | 2022-2023 | Exparel |
| Acell, INC. | $44.77 | 2019 | |
| Astellas Pharma US INC | $40.91 | 2019 | |
| Ethicon US, LLC | $38.65 | 2019-2023 | Echelon Flex |
| Organogenesis INC. | $30.67 | 2019 | |
| Polynovo North America LLC | $25.17 | 2024 | Novosorb Btm |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eagle Pharmaceuticals, INC. | $25.07 | 2023 | |
| Angiodynamics, INC. | $20.24 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $18.75 | 2019 | |
| Kci USA, INC. | $16.44 | 2019 | |
| Merck Sharp & Dohme LLC | $16.28 | 2022 | |
| Medtronic USA, INC. | $12.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Moreno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.